Catheter Occlusion: Causes and Solutions
Author(s): McKinnon Barbara, Lima Hetty A
Issue: Sep/Oct 1998 - Parenteral Nutrition Solutions
View All Articles in Issue
Page(s): 342-346
Download in electronic PDF format for $75
Abstract: With the increasing use of long-term venous access devices for chronic administration of medications and nutrients, catheter occlusion is a frequently encountered problem. In this article, the authors discuss mechanical occlusion, thrombotic occlusion, precipitates (calcium-phosphate precipitation and drug precipitates) and lipid residue. They conclude that today it is possible to preserve venous access for the vast majority of patients with an occluded catheter. Benefits of catheter salvage include avoidance of the cost, pain and inconvenience of catheter replacement; preservation of limited venous access sites and rapid restoration of venous access for needed therapies.
Related Keywords:
Filter, Millipore
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Catheter Occlusion: Causes and Solutions
McKinnon Barbara, Lima Hetty A
|
Sep/Oct 1998
Pg. 342-346
|
Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions
Ohara Hiroshi, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka
|
Sep/Oct 2020
Pg. 420-425
|
Sterile Filtration
Akers Michael J
|
Mar/Apr 2024
Pg. 120-127
|
Sterile Filtration
Akers Michael J
|
Sep/Oct 2015
Pg. 393-401
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015
Pg. 334-336
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Sore Nipples in Breastfeeding Mothers: Causes and Treatments
Albright Lisa M
|
Nov/Dec 2003
Pg. 426-435
View Sample |
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 456
|
Root Cause Analysis, Part 1: Nonsterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Nov/Dec 2015
Pg. 465-469
|
Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Mar/Apr 2016
Pg. 99-104
|
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
|
Sep/Oct 2015
Pg. 367-373
|
Paclitaxel Compatibility with IV Express Filter Unit
Xu Quanyun A, Trissel Lawrence A, Zhang Yanping
|
May/Jun 1998
Pg. 243-245
|
Sorption of Benzalkonium Chloride to Various Filters Used in Ophthalmics
Prince Shelly J, Allen Loyd V Jr
|
May/Jun 1998
Pg. 249-251
|
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise, Blackburn Paul L
|
Mar/Apr 2013
Pg. 100-110
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
|
Jan/Feb 2009
Pg. 53-55
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Williams LaVonn
|
Jul/Aug 2018
Pg. 284-287
|
| Return to Top |
